↓ Skip to main content

A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial

Overview of attention for article published in BMC Psychiatry, June 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users
facebook
2 Facebook pages

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
289 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial
Published in
BMC Psychiatry, June 2018
DOI 10.1186/s12888-018-1752-5
Pubmed ID
Authors

M. Deady, D. A. Johnston, N. Glozier, D. Milne, I. Choi, A. Mackinnon, A. Mykletun, R. A. Calvo, A. Gayed, R. Bryant, H. Christensen, S. B. Harvey

Abstract

Depression is a commonly occurring disorder linked to diminished role functioning and quality of life. The development of treatments that overcome barriers to accessing treatment remains an important area of clinical research as most people delay or do not receive treatment at an appropriate time. The workplace is an ideal setting to roll-out an intervention, particularly given the substantial psychological benefits associated with remaining in the workforce. Mobile health (mhealth) interventions utilising smartphone applications (apps) offer novel solutions to disseminating evidence based programs, however few apps have undergone rigorous testing. The present study aims to evaluate the effectiveness of a smartphone app designed to treat depressive symptoms in workers. The present study is a multicentre randomised controlled trial (RCT), comparing the effectiveness of the intervention to that of an attention control. The primary outcome measured will be reduced depressive symptoms at 3 months. Secondary outcomes such as wellbeing and work performance will also be measured. Employees from a range of industries will be recruited via a mixture of targeted social media advertising and Industry partners. Participants will be included if they present with likely current depression at baseline. Following baseline assessment (administered within the app), participants will be randomised to receive one of two versions of the Headgear application: 1) Intervention (a 30-day mental health intervention focusing on behavioural activation and mindfulness), or 2) attention control app (mood monitoring for 30 days). Participants will be blinded to their allocation. Analyses will be conducted within an intention to treat framework using mixed modelling. The results of this trial will provide valuable information about the effectiveness of mhealth interventions in the treatment of depressive symptoms in a workplace context. The current trial is registered with the Australian and New Zealand Clinical Trials Registry ( ACTRN12617000547347 , Registration date: 19/04/2017).

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 289 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 289 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 40 14%
Student > Ph. D. Student 39 13%
Student > Bachelor 31 11%
Researcher 23 8%
Student > Doctoral Student 16 6%
Other 48 17%
Unknown 92 32%
Readers by discipline Count As %
Psychology 60 21%
Medicine and Dentistry 34 12%
Nursing and Health Professions 25 9%
Computer Science 10 3%
Business, Management and Accounting 9 3%
Other 39 13%
Unknown 112 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2019.
All research outputs
#13,615,073
of 23,085,832 outputs
Outputs from BMC Psychiatry
#2,892
of 4,766 outputs
Outputs of similar age
#170,529
of 330,312 outputs
Outputs of similar age from BMC Psychiatry
#103
of 124 outputs
Altmetric has tracked 23,085,832 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,766 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,312 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.